AJP - Heart Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 288: H2708-H2714, 2005. First published January 21, 2005; doi:10.1152/ajpheart.01017.2003
0363-6135/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/6/H2708    most recent
01017.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paetsch, I.
Right arrow Articles by Nagel, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paetsch, I.
Right arrow Articles by Nagel, E.

Magnetic resonance stress tagging in ischemic heart disease

Ingo Paetsch,1,* Daniela Föll,2,* Adam Kaluza,1 Roger Luechinger,3 Matthias Stuber,4 Axel Bornstedt,1 Andreas Wahl,1 Eckart Fleck,1 and Eike Nagel1

1Department of Cardiology, German Heart Institute, Berlin; 2Department of Cardiology and Angiology, University of Freiburg, Freiburg, Germany; 3Institute for Biomedical Engineering, University and ETH, Zurich, Switzerland; and 4Department of Radiology, Johns Hopkins University, Baltimore, Maryland

Submitted 28 October 2003 ; accepted in final form 4 January 2005

High-dose dobutamine magnetic resonance stress testing has been shown to be superior to dobutamine stress echocardiography for diagnosis of coronary artery disease (CAD). We determined the feasibility of quantitative myocardial tagging during low- and high-dose dobutamine stress and tested the ability of global systolic and diastolic quantitative parameters to identify patients with significant CAD. Twenty-five patients suspected of having significant CAD were examined with a standard high-dose dobutamine/atropine stress magnetic resonance protocol (1.5-T scanner, Philips). All patients underwent invasive coronary angiography as the standard of reference for the presence (n = 13) or absence (n = 12) of significant CAD. During low-dose dobutamine stress, systolic (circumferential shortening, systolic rotation, and systolic rotation velocity) and diastolic (velocity of circumferential lengthening and diastolic rotation velocity) parameters changed significantly in patients without CAD (all P < 0.05 vs. rest) but not in patients with CAD. Identification of patients without and with CAD during low-dose stress was possible using the diastolic parameter of "time to peak untwist." At high-dose stress, none of the global systolic or diastolic parameters showed the potential to identify the presence of significant CAD. With myocardial tagging, a quantitative analysis of systolic and diastolic function was feasible during low- and high-dose dobutamine stress. In our study, the diastolic parameter of time to peak untwist as assessed during low-dose dobutamine stress was the most promising global parameter for identification of patients with significant CAD. Thus quantitative myocardial tagging may become a tool that reduces the need for high-dose dobutamine stress.

dobutamine; echocardiography; systolic rotation velocity; time to peak untwist; diastolic rotation velocity



Address for reprint requests and other correspondence: E. Nagel, German Heart Institute Berlin, Augustenburger Platz 1, 13353 Berlin, Germany (E-mail: eike.nagel{at}dhzb.de)




This article has been cited by other articles:


Home page
CirculationHome page
T. Lockie, E. Nagel, S. Redwood, and S. Plein
Use of Cardiovascular Magnetic Resonance Imaging in Acute Coronary Syndromes
Circulation, March 31, 2009; 119(12): 1671 - 1681.
[Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
G. Korosoglou, D. Lossnitzer, D. Schellberg, A. Lewien, A. Wochele, T. Schaeufele, M. Neizel, H. Steen, E. Giannitsis, H. A. Katus, et al.
Strain-Encoded Cardiac MRI as an Adjunct for Dobutamine Stress Testing: Incremental Value to Conventional Wall Motion Analysis
Circ Cardiovasc Imaging, March 1, 2009; 2(2): 132 - 140.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
I. Paetsch, C. Jahnke, V. A. Ferrari, F. E. Rademakers, P. A. Pellikka, W. G. Hundley, D. Poldermans, J. J. Bax, K. Wegscheider, E. Fleck, et al.
Determination of interobserver variability for identifying inducible left ventricular wall motion abnormalities during dobutamine stress magnetic resonance imaging
Eur. Heart J., June 2, 2006; 27(12): 1459 - 1464.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.